Intralesional Injection ofMycobacterium wVaccine vs Imiquimod, 5%, Cream in Patients With Anogenital Warts
Authors:
- 1 October 2014
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Dermatology
- Vol. 150 (10) , 1072-1078
Abstract
Research from JAMA Dermatology — Intralesional Injection of Mycobacterium w Vaccine vs Imiquimod, 5%, Cream in Patients With Anogenital Warts — A Randomized Clinical TrialKeywords
This publication has 10 references indexed in Scilit:
- Intralesional Immunotherapy With Mycobacteriumw Vaccine in Patients With Multiple Cutaneous Warts: Uncontrolled Open StudyJAMA Dermatology, 2013
- Activation of Anti-Tumor Immune Response and Reduction of Regulatory T Cells with Mycobacterium indicus pranii (MIP) Therapy in Tumor Bearing MicePLOS ONE, 2011
- Intradermal injection of PPD as a novel approach of immunotherapy in anogenital warts in pregnant womenDermatologic Therapy, 2011
- Polyphasic Taxonomic Analysis Establishes Mycobacterium indicus pranii as a Distinct SpeciesPLOS ONE, 2009
- Real-time Taqman PCR targeting 14 human papilloma virus typesJournal of Clinical Virology, 2007
- Molecular Classification Identifies a Subset of Human Papillomavirus–Associated Oropharyngeal Cancers With Favorable PrognosisJournal of Clinical Oncology, 2006
- Intralesional Immunotherapy for Genital WartsArchives of Dermatology, 2005
- Using Imiquimod for Genital Warts in Female PatientsJournal of Women's Health, 2004
- Tolerance or Immunity to a Tumor Antigen Expressed in Somatic Cells Can Be Determined by Systemic Proinflammatory Signals at the Time of First Antigen ExposureThe Journal of Immunology, 2001
- Imiquimod, a Patient-Applied Immune-Response Modifier for Treatment of External Genital WartsAntimicrobial Agents and Chemotherapy, 1998